COVID-19 management: The vaccination drive in India.

COVID-19 Healthcare policies India Pandemic Vaccination

Journal

Health policy and technology
ISSN: 2211-8837
Titre abrégé: Health Policy Technol
Pays: Netherlands
ID NLM: 101597449

Informations de publication

Date de publication:
Jun 2022
Historique:
revised: 20 04 2022
accepted: 25 04 2022
pubmed: 10 5 2022
medline: 10 5 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

We undertook the study to present a comprehensive overview of COVID-19 related measures, largely centred around the development of vaccination related policies, their implementation and challenges faced in the vaccination drive in India. A targeted review of literature was conducted to collect relevant data from official government documents, national as well as international databases, media reports and published research articles. The data were summarized to assess Indian government's vaccination campaign and its outcomes as a response to COVID-19 pandemic. The five-point strategy adopted by government of India was "COVID appropriate behaviour, test, track, treat and vaccinate". With respect to vaccination, there have been periodic shifts in the policies in terms of eligible beneficiaries, procurement, and distribution plans, import and export strategy, involvement of private sector and use of technology. The government utilized technology for facilitating vaccination for the beneficiaries and monitoring vaccination coverage. The monopoly of central government in vaccine procurement resulted in bulk orders at low price rates. However, the implementation of liberalized policy led to differential pricing and delayed achievement of set targets. The population preference for free vaccines and low profit margins for the private sector due to price caps resulted in a limited contribution of the dominant private health sector of the country. A wavering pattern was observed in the vaccination coverage, which was related majorly to vaccine availability and hesitancy. The campaign will require consistent monitoring for timely identification of bottlenecks for the lifesaving initiative.

Identifiants

pubmed: 35531441
doi: 10.1016/j.hlpt.2022.100636
pii: S2211-8837(22)00041-7
pmc: PMC9069978
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100636

Informations de copyright

© 2022 Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

None declared

Références

Brain Behav Immun. 2021 Aug;96:1-4
pubmed: 34022371
Int J Health Plann Manage. 2022 May;37(3):1847-1850
pubmed: 34510541
Biomed Res Int. 2021 Aug 26;2021:6658070
pubmed: 34485525
Front Microbiol. 2020 Jul 14;11:1526
pubmed: 32760367
Lancet Glob Health. 2021 Sep;9(9):e1197-e1200
pubmed: 34217378
Vaccines (Basel). 2021 Sep 24;9(10):
pubmed: 34696172
Nature. 2021 Apr;592(7855):500-501
pubmed: 33854229

Auteurs

Neha Purohit (N)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Yashika Chugh (Y)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Pankaj Bahuguna (P)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Shankar Prinja (S)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Classifications MeSH